Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1983 Feb;78(2):329–337. doi: 10.1111/j.1476-5381.1983.tb09398.x

The effects of nicotine on locomotor activity in non-tolerant and tolerant rats.

P B Clarke, R Kumar
PMCID: PMC2044704  PMID: 6131718

Abstract

1--Rats were tested for locomotor activity in photocell cages, for 80 min starting immediately after subcutaneous injection of (-)-nicotine bitartrate or 0.9% w/v NaCl solution (saline). In non-tolerant subjects, nicotine (0.1 to 0.4 mg/kg base) depressed activity and induced ataxia in the first 20 min, but increased activity later in the session; these actions were dose-dependent. 2--Tolerance was studied by comparing rats given nicotine (0.4 mg/kg s.c.) every day with control rats given saline instead. Each week, every subject was tested once with nicotine (0.4 mg/kg) and once with saline. With daily or even weekly injections of nicotine, the initial depressant action of the drug was replaced by a dose-dependent stimulant action which occurred throughout the session. In these tolerant animals, little ataxia was seen except when a larger dose of 0.8 mg/kg was given. Tolerance to the depressant action of nicotine persisted for at least 3 weeks. 3--In non-tolerant subjects, mecamylamine (0.5, 1.0 mg/kg s.c.) prevented the initial depressant action of nicotine (0.4 mg/kg). In tolerant rats, the locomotor stimulant action of nicotine (0.4 mg/kg) was prevented by mecamylamine (0.1, 0.32, 1.0 mg/kg s.c.) in a dose-related way; the quaternary ganglion blocker, hexamethonium (0.2, 1.0, 5.0 mg/kg s.c.) had little or no such effect. Neither mecamylamine nor hexamethonium altered activity when given alone. 4--It is suggested that a few treatments with nicotine can unmask a stimulant action of the drug, probably of central origin, which possibly reflects a stimulation of nicotine receptors.

Full text

PDF
329

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ascher P., Large W. A., Rang H. P. Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells. J Physiol. 1979 Oct;295:139–170. doi: 10.1113/jphysiol.1979.sp012958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BENNETT G., TYLER C., ZAIMIS E. Mecamylamine and its mode of action. Lancet. 1957 Aug 3;273(6988):218–222. doi: 10.1016/s0140-6736(57)91598-2. [DOI] [PubMed] [Google Scholar]
  3. Bättig K., Driscoll P., Schlatter J., Uster H. J. Effects of nicotine on the exploratory locomotion patterns of female Roman high- and low-avoidance rats. Pharmacol Biochem Behav. 1976 Apr;4(4):435–439. doi: 10.1016/0091-3057(76)90060-5. [DOI] [PubMed] [Google Scholar]
  4. Domino E. F., Lutz M. P. Tolerance to the effects of daily nicotine on rat bar pressing behavior for water reinforcement. Pharmacol Biochem Behav. 1973 Jul-Aug;1(4):445–448. doi: 10.1016/0091-3057(73)90011-7. [DOI] [PubMed] [Google Scholar]
  5. Gilbert D. G. Paradoxical tranquilizing and emotion-reducing effects of nicotine. Psychol Bull. 1979 Jul;86(4):643–661. [PubMed] [Google Scholar]
  6. Goldberg S. R., Spealman R. D., Goldberg D. M. Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science. 1981 Oct 30;214(4520):573–575. doi: 10.1126/science.7291998. [DOI] [PubMed] [Google Scholar]
  7. LEVINE R. R. The physiological disposition of hexamethonium and related compounds. J Pharmacol Exp Ther. 1960 Jul;129:296–304. [PubMed] [Google Scholar]
  8. Morrison C. F. Effects of nicotine on operant behaviour of rats. Int J Neuropharmacol. 1967 May;6(3):229–240. doi: 10.1016/0028-3908(67)90010-x. [DOI] [PubMed] [Google Scholar]
  9. Morrison C. F., Goodyear J. M., Sellers C. M. Antagonism by antimuscarinic and ganglion-blocking drugs of some of the behavioural effects of nicotine. Psychopharmacologia. 1969;15(5):341–350. doi: 10.1007/BF00403709. [DOI] [PubMed] [Google Scholar]
  10. Morrison C. F., Stephenson J. A. The occurrence of tolerance to a central depressant effect of nicotine. Br J Pharmacol. 1972 Sep;46(1):151–156. doi: 10.1111/j.1476-5381.1972.tb06857.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Newman L. M. Effects of cholinergic agonists and antagonists on self-stimulation behavior in the rat. J Comp Physiol Psychol. 1972 Jun;79(3):394–413. doi: 10.1037/h0032830. [DOI] [PubMed] [Google Scholar]
  12. Pradhan S. N., Bowling C. Effects of nicotine on self-stimulation in rats. J Pharmacol Exp Ther. 1971 Jan;176(1):229–243. [PubMed] [Google Scholar]
  13. Pradhan S. N. Effects of nicotine on several schedules of behavior in rats. Arch Int Pharmacodyn Ther. 1970 Jan;183(1):127–138. [PubMed] [Google Scholar]
  14. Rosecrans J. A. Brain area nicotine levels in male and female rats with different levels of spontaneous activity. Neuropharmacology. 1972 Nov;11(6):863–870. doi: 10.1016/0028-3908(72)90045-7. [DOI] [PubMed] [Google Scholar]
  15. Rosecrans J. A., Schechter M. D. Brain area nicotine levels in male and female rats of two strains. Arch Int Pharmacodyn Ther. 1972 Mar;196(1):46–54. [PubMed] [Google Scholar]
  16. STONE C. A., TORCHIANA M. L., NAVARRO A., BEYER K. H. Ganglionic blocking properties of 3-methylaminoisocamphane hydrochloride (mecamylamine): a secondary amine. J Pharmacol Exp Ther. 1956 Jun;117(2):169–183. [PubMed] [Google Scholar]
  17. Schweitzer A., Wright S. Action of nicotine on the spinal cord. J Physiol. 1938 Oct 14;94(1):136–147. doi: 10.1113/jphysiol.1938.sp003668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Spealman R. D., Goldberg S. R., Gardner M. L. Behavioral effects of nicotine: schedule-controlled responding by squirrel monkeys. J Pharmacol Exp Ther. 1981 Mar;216(3):484–491. [PubMed] [Google Scholar]
  19. Stolerman I. P., Bunker P., Jarvik M. E. Nicotine tolerance in rats; role of dose and dose interval. Psychopharmacologia. 1974 Feb 6;34(4):317–324. doi: 10.1007/BF00422555. [DOI] [PubMed] [Google Scholar]
  20. Stolerman I. P., Fink R., Jarvik M. E. Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia. 1973 Jun 29;30(4):329–342. doi: 10.1007/BF00429192. [DOI] [PubMed] [Google Scholar]
  21. Tang A. H., Yim G. K. The effects of arecoline on spinal reflexes of the cat. Int J Neuropharmacol. 1965 Nov;4(6):309–316. doi: 10.1016/0028-3908(65)90010-9. [DOI] [PubMed] [Google Scholar]
  22. Turner D. M. The effects of some tobacco smoke constituents on foreign compound metabolism in the cat and the rat. Res Commun Chem Pathol Pharmacol. 1977 Mar;16(3):425–442. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES